Global Agrobacterium tumefaciens Competent Cells Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Agrobacterium tumefaciens Competent Cells Market Insights, Forecast to 2034
Agrobacterium tumefaciens (Rhizobium radiobactor) is capable of T-DNA transfer to plant cells. The T-DNA (transfer DNA) is located in the Ti plasmid and is capable of integration into the host plant chromosomal DNA.
Global Agrobacterium tumefaciens Competent Cells market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Agrobacterium tumefaciens Competent Cells industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Agrobacterium tumefaciens Competent Cells key manufacturers include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Agrobacterium tumefaciens Competent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Agrobacterium tumefaciens Competent Cells market and estimated to attract more attentions from industry insiders and investors.
Agrobacterium tumefaciens Competent Cells can be divided into 20*100μl, 50*100μl, 100*100μl and Other, etc. 20*100μl is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Agrobacterium tumefaciens Competent Cells is widely used in various fields, such as Mutagenesis, Single-Stranded Dna Production, Bacmid creation and Cre-lox recombination (PIR1/PIR2), etc. Mutagenesis provides greatest supports to the Agrobacterium tumefaciens Competent Cells industry development. In 2022, global % sales of Agrobacterium tumefaciens Competent Cells went into Mutagenesis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Agrobacterium tumefaciens Competent Cells market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Agrobacterium tumefaciens Competent Cells market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Segment by Type
20*100μl
50*100μl
100*100μl
Other
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Agrobacterium tumefaciens Competent Cells plant distribution, commercial date of Agrobacterium tumefaciens Competent Cells, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Agrobacterium tumefaciens Competent Cells introduction, etc. Agrobacterium tumefaciens Competent Cells Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Agrobacterium tumefaciens Competent Cells
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Agrobacterium tumefaciens Competent Cells market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Agrobacterium tumefaciens Competent Cells industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Agrobacterium tumefaciens Competent Cells key manufacturers include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Agrobacterium tumefaciens Competent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Agrobacterium tumefaciens Competent Cells market and estimated to attract more attentions from industry insiders and investors.
Agrobacterium tumefaciens Competent Cells can be divided into 20*100μl, 50*100μl, 100*100μl and Other, etc. 20*100μl is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Agrobacterium tumefaciens Competent Cells is widely used in various fields, such as Mutagenesis, Single-Stranded Dna Production, Bacmid creation and Cre-lox recombination (PIR1/PIR2), etc. Mutagenesis provides greatest supports to the Agrobacterium tumefaciens Competent Cells industry development. In 2022, global % sales of Agrobacterium tumefaciens Competent Cells went into Mutagenesis filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Agrobacterium tumefaciens Competent Cells market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Agrobacterium tumefaciens Competent Cells market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Segment by Type
20*100μl
50*100μl
100*100μl
Other
Segment by Application
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Agrobacterium tumefaciens Competent Cells plant distribution, commercial date of Agrobacterium tumefaciens Competent Cells, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Agrobacterium tumefaciens Competent Cells introduction, etc. Agrobacterium tumefaciens Competent Cells Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Agrobacterium tumefaciens Competent Cells
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports